We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
- Authors
Romaguera, Jorge E; Fayad, Luis; Rodriguez, Maria A; Broglio, Kristine R; Hagemeister, Frederick B; Pro, Barbara; McLaughlin, Peter; Younes, Anas; Samaniego, Felipe; Goy, Andre; Sarris, Andreas H; Dang, Nam H; Wang, Michael; Beasley, Virginia; Medeiros, L Jeffrey; Katz, Ruth L; Gagneja, Harish; Samuels, Barry I; Smith, Terry L; Cabanillas, Fernando F
- Abstract
To determine the response, failure-free survival (FFS), and overall survival rates and toxicity of rituximab plus an intense chemotherapy regimen in patients with previously untreated aggressive mantle-cell lymphoma (MCL).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 28, p7013
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.01.1825